Mimics and cross reactions of relevance to tumour immunotherapy

Vaccine

Volumn 18, Issue 3-4, 1999, Pages 268-275

  Apostolopoulos, Vasso ^a   Sandrin, Mauro S ^a   McKenzie, Ian F C ^a  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

Author keywords

Cross reactions; Mimics; MUC1

Indexed keywords

EPITOPE; SYNTHETIC PEPTIDE; TUMOR ANTIGEN; TUMOR VACCINE;

AMINO ACID SEQUENCE; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; BREAST CANCER; CANCER IMMUNOTHERAPY; CONFERENCE PAPER; CROSS REACTION; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SWINE; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNE DISEASES; CROSS REACTIONS; HUMANS; IMMUNOTHERAPY; MICE; MOLECULAR MIMICRY; NEOPLASMS, EXPERIMENTAL; SEQUENCE ANALYSIS, PROTEIN; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032825352     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00197-8     Document Type: Conference Paper

References (39)

1. Xing P.X., Tjandra J.J., Stacker S.A., Teh J.G., Thompson C.H., McLaughlin P.J., McKenzie I.F.C. Monoclonal antibodies reactive with mucin expressed in breast cancer. Immunol Cell Biol. 67:1989;183-195.
2. Xing P.X., Reynolds K., Tjandra J.J., Tang X.L., McKenzie I.F.C. Synthetic peptides reactive with anti-human milk fat globule membrane monoclonal antibodies. Cancer Res. 50:1990;89-96.
3. Gendler S.J., Papadimitriou J.T., Duhig T., Rothbard J., Burchell J. A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J Biol Chem. 263:1989;12820-12823.
4. Barnd D.L., Lan M.S., Metzgar R.S., Finn O.J. Specific major histocompatibility complex-unrestricted recognition of tumour associated mucins by human cytotoxic T cells. Proc Natl Acad Sci USA. 86:1989;7159-7163.
5. Ioannides C.G., Fisk B., Jerome K.R., Irimura T., Wharton J.T., Finn O.J. Cytotoxic T cells from ovarian malignant tumours can recognize polymorphic epithelial mucin core peptides. J Immunol. 151:1993;3693-3703.
6. Jerome K.R., Domenech N., Finn O.J. Tumour-specific CTL clones from patients with breast and pancreatic adenocarcinoma recognise EBV-immortalised B cells transfected with polymorphic epithelial mucin cDNA. J Immunol. 151:1993;1654-1662.
7. Domenech N., Henderson R.A., Finn O.J. Identification of an HLA-A11-restricted epitope from the tandem repeat of the epithelial tumour antigen MUC1. J Immunol. 155:1995;4766-4774.
8. Agrawal B., Reddish M.A., Longenecker B.M. In vitro induction of MUC-1 peptide-specific type 1 T lymphocyte and cytotoxic T lymphocyte responses from healthy multiparous donors. J Immunol. 157:1996;2089-2095.
9. Rughetti A., Turchi V., Ghetti C.A., Scambia G., Panici P.B., Roncucci G., Mancuso S., Frati L., Nuti M. Human B-cell immune response to the polymorphic epithelial mucin. Cancer Res. 53:1993;2457-2459.
10. von Mensdorff-Pouilly S., Gourevitch M.M., Kenemans P., Verstraeten A., Litvinov S.V., van Kamp G.J., Meijer S., Vermorken J., Hilgers J. Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours. Eur J Cancer. 32:1996;1325-1331.
11. Kotera Y., Fontenont J.D., Pecher G., Metzgar R.S., Finn O.J. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic and colon cancer patients. Cancer Res. 54:1994;2856-2860.
12. Gourevitch M.M., von Mensdorff-Pouilly S., Litvinov S.V., Kenemans P., van Kamp G.J., Verstraeten A.A., Hilgers J. Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients. Br J Cancer. 72:1995;934-938.
13. Apostolopoulos V., Pietersz G.A., McKenzie I.F.C. Cell-mediated immune responses to MUC1 fusion protein coupled to mannan. Vaccine. 14:1996;930-938.
14. 2 immune responses. Proc Natl Acad Sci USA. 92:1995;10128-10132.
15. Apostolopoulos V., Loveland B.E., Pietersz G.A., McKenzie I.F.C. CTL in mice immunised with human Mucin 1 are MHC-restricted. J Immunol. 155:1995;5089-5094.
16. Karanikas V., Hwang L., Pearson J., Ong C.S., Apostolopoulos V., Vaughan H., Xing P.X., Jamieson G., Pietersz G.A., Tait B., Broadbent R., Thynne G., McKenzie I.F.C. Antibody and T cell responses of patients with adenocarcinoma immunised with mannan-MUC1 fusion protein. J Clinical Invest. 100:1997;2783-2792.
17. Apostolopoulos V., Xing P.X., McKenzie I.F.C. Murine immune response to cells transfected with human MUC1: immunisation with cellular and synthetic antigens. Cancer Res. 54:1994;5186-5193.
18. Apostolopoulos V., Pietersz G.A., Xing P.X., Lees C., Michaels M., Bishop J., McKenzie I.F.C. The immunogenicity of MUC1 peptides and fusion protein. Cancer Lett. 90:1995;21-26.
19. Pietersz G.A., Wenjun L., Popovski V., Caruana J.A., Apostolopoulos V., McKenzie I.F.C. Parameters in using mannan-fusion protein (M-FP) to induce cellular immunity. Cancer Immunol Immunother. 45:1998;321-326.
20. 2 (antibody) response to a mucin-1 tumour antigen. Vaccine. 15:1997;1586-1593.
21. Apostolopoulos V., Haurum J.S., McKenzie I.F.C. MUC1 peptide epitopes associated with 5 different H2 class I molecules. Eur J Immunol. 27:1997;2579-2587.
22. Apostolopoulos V., Karanikas V., Haurum J., McKenzie I.F.C. Induction of HLA- A2 restricted cytotoxic T lymphocytes to the MUC1 human breast cancer antigen. J Immunol. 159:1997;5211-5218.
23. Vaughan H.A., Loveland B.E., Sandrin M.S. Galα(1,3)Gal is the major xenoepitope expressed on pig endothelial cells recognized by naturally occurring cytotoxic antibodies. Transplantation. 58:1994;879-884.
24. Sandrin M.S., Vaughan H.A., Dabkowski P.L., McKenzie I.F.C. Anti-pig antibodies in human serum predominantly with galα(1,3)gal epitopes. Proc Natl Acad Sci USA. 90:1995;11391-11395.
25. Galili U. Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today. 14:1993;480-482.
26. Hayes C.E., Goldstein I.J. An alpha-D-galactosyl-binding lectin from Bandeiraea simplicifolia seeds. Isolation by affinity chromatography and characterization. J Biol Chem. 249:1974;1904-1914.
27. Galili U., Shohet S.B., Kobrin E., Stults C.L.M., Macher B.A. Man, apes, and old world monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem. 263:1988;17733-17762.
28. Joziasse D.H., Shaper J.H., Jabs E.W., Shaper N.C. Characterization of an alpha 1-3-galactosyltransferase homologue on human chromosome 12 that is organized as a processed pseudogene. J Biol Chem. 266:1991;6991-6998.
29. Larsen R.D., Rivera-Marrero C.A., Ernst L.K., Cummings R.D., Lowe J.B. Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal:beta-D-Gal(1,4)-D-GlcNAc alpha(1,3)-galactosyltransferase cDNA. J Biol Chem. 265:1990;7055-7061.
30. Vaughan H.A., Oldenburg K.R., Gallop M.A., Atkin J.D., McKenzie I.F.C., Sandrin M.S. Recognition of an octapeptide sequence by multiple Galα(1,3)Gal-binding proteins. Xenotransplantation. 3:1996;18-23.
31. Sandrin M.S., Vaughan H.A., Xing P.X., McKenzie I.F.C. Natural human anti galα(1,3)gal antibodies react with human mucin peptides. Glycoconj J. 14:1997;97-105.
32. Apostolopoulos V., Lofthouse S.A., Popovski V., Chevanayagam G., Sandrin M.S., McKenzie I.F.C. Peptide mimics of a tumour antigen induce functional cytotoxic T cells. Nature Biotech. 16:1998;276-280.
33. Xing P.X., Apostolopoulos V., Michaels M., Prenzoska J., Bishop J., McKenzie I.F.C. Phase I study of synthetic MUC1 peptides in cancer. Int J Oncol. 6:1995;1283-1289.
34. Apostolopoulos V., Osinski C., McKenzie I.F.C. MUC1 cross reactive Galα(1,3)Gal antibodies in humans switch immune responses from cellular to humoral. Nature Med. 4:1998;315-320.
35. Galili U., La Temple C. Natural anti-Gal antibody as a universal augmentor of autologous tumour vaccine immunogenicity. Immunol Today. 18:1997;281-285.
36. Henion T.R., Gerhard W., Anaraki F., Galili U. Synthesis of alpha-gal epitopes on influenza virus vaccines, by recombinant alpha 1,3 galactosyltransferase, enables the formation of immune complexes with the natural anti-Gal antibody. Vaccine. 15:1997;1174-1182.
37. Celis E., Abraham K.G., Miller R.W. Modulation of the immunological response to hepatitis B virus by antibodies. Hepatology. 7:1987;563-568.
38. Bouige P., Iscaki S., Cosson A., Pillot J. Molecular analysis of the modulatory factors of the response to HBsAg in mice as an approach to HBV vaccine enhancement. Immunol Med Microbiol. 13:1996;71-79.
39. Galili U., Repik P.M., Anaraki F., Mozdzanowska K., Washko G., Gerhard W. Enhancement of antigen presentation of influenza virus hemagglutinin by the natural human anti-Gal antibody. Vaccine. 14:1996;321-328.